Cargando…
193. Rapid Diagnostic Testing and Vancomycin Utilization for Contaminated Blood Cultures
BACKGROUND: Bacteremia is a prevalent hospital acquired infection that affects nearly one in ten hospitalized patients. Rates of contaminated blood cultures have ranged from 0.6% to 6% in the literature. Vancomycin is often chosen as empiric coverage for gram positive organisms while awaiting bacter...
Autores principales: | Lockridge, Connor, Paciullo, Kristen, Trible, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751564/ http://dx.doi.org/10.1093/ofid/ofac492.271 |
Ejemplares similares
-
193. Standard of Care versus Alternative Beta-lactams for Treatment of Infections due to Serratia marcescens
por: Green, Sarah B, et al.
Publicado: (2023) -
188. Opportunities for antimicrobial stewardship: Time to optimal therapy and vancomycin use in gram-positive and contaminated blood cultures before and after implementation of rapid blood culture diagnostic testing
por: Olion, Kelsey, et al.
Publicado: (2022) -
2007. Impact of Combining Rapid Diagnostics with an Interpretation Guide on Vancomycin Usage for Contaminant Blood Cultures Growing Coagulase-Negative Staphylococci (CoNS)
por: Wu, Simon, et al.
Publicado: (2019) -
Costs of Blood Culture Contamination: Justification for Rapid Diagnostics in a Community Hospital
por: Kassamali, Zahra, et al.
Publicado: (2017) -
1802. Evaluation of Clinical Pharmacists Use of a Blood Culture Follow-up Protocol Utilizing Rapid Molecular Diagnostic Testing
por: Kerrigan, Alexandra, et al.
Publicado: (2018)